Infectious agents and different course of multiple sclerosis: a systematic review
Multiple sclerosis (MS) causes demyelination of white matter of central nervous system and neuro-degeneration due to inflammation. Different types of MS, as well as disease progression, come with different pathology and pathophysiology. The objective of this study was to evaluate the possible association between different micro-organisms and the relapse or progression of MS. Studies indexed in Medline/PMC, Scopus and Web of Science published without time and language limitation until March 2017 were identified through the search terms “infection” or “infectious” and “multiple sclerosis”. A total of 20878 abstracts were identified through the initial search terms. Selection of articles and assessment of their quality was done based on Cochrane library guidelines. Full texts were reviewed for 33 articles out of which 14 articles met the criteria for inclusion. Different micro-organisms are known to play roles in the pathogenesis of MS and its relapse; including Human herpesvirus 6 (HHV-6), Human herpesvirus 7 (HHV-7), Epstein–Barr virus (EBV), Chlamydia pneumoniae and Torque teno virus (TTV). But in this review only HHV-6, C. pneumoniae and TTV have been considered to play a role in disease progression in some studies and not all of them. This review concluded that some micro-organisms such as HHV-6, C. pneumoniae and TTV have been considered as cofactors to make MS a progressive type. It should be considered that these findings do not necessarily rule out the role of other pathogens in MS progression but may represent population differences or different sensitivity of the technique used.
KeywordsInfection Multiple sclerosis Relapsing–remitting Progressive
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
The authors confirm independence from the sponsors; the content of the article has not been influenced by the sponsors.
- 5.Semnani M, Mashayekhi F, Azarnia M, Salehi Z (2016) Effects of green tea epigallocatechin-3-gallate (EGCG) on proteolipid protein (PLP) and oligodendrocyte transcription factor 1 (Olig1) expression in the cerebral cortex of cuprizone induced multiple sclerosis mice; a western blot study. Caspian J Neurol Sci 2(6):1–9CrossRefGoogle Scholar
- 10.Saberi A, Roudbary SA, Hatamian HR, Akbari MS, Sedigh-Rahim-Abadi MR (2012) The type of multiple sclerosis when accompanied with seizure: can seizure predict the progression of MS? Akt Neurol 39:1–5. (text in German) Google Scholar
- 12.Lublin DF, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907–11Google Scholar
- 18.Ashtari F, Saberi A, Shayegannejad V, Khosravi AR, Sherkat R, Khosravi E (2007) Association between Chlamydia pneumoniae infection and carotid atherosclerotic plaques. JRMS 12(4):165–171Google Scholar
- 19.Ashtari F, Shayghannejad V, Saberi A, Karkheyran F, Khosravi E (2007) Chlamydia pneumonia infection and thrombotic ischemic stroke. J Isfahan Med School 24(83):8–14 [Text in Persian].Google Scholar
- 20.Ashtari F, Shayegannejad V, Khosravi AR, Alia Saberi A, Niknazar MA (2006) The influence of Chlamydia pneumoniae infection on Intima-Media-thickness (IMT) in common carotid artery. ARYA Atheroscler 2(3):130–133Google Scholar
- 21.Ashtari F, Shayghannejad V, Saberi A, Rabiei E (2006) Association between Helicobacter pylori infection and carotid atherosclerotic plaque. Iran J Neurol 5(14):8–14Google Scholar
- 22.Ashtari F, Shayegannejad V, Saberi A, Rabiei E (2008) Relationship between Helicobacter pylori immunoglobulin g antibody and thrombotic ischemic stroke. Acta Medica Iranica 46(4):303–306Google Scholar
- 38.Sherbet G (2009) Bacterial infections and the pathogenesis of autoimmune conditions. Br J Med Pract 2:6–13Google Scholar
- 56.Nora-Krukle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M (2011) Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas) 47(10):527–531Google Scholar
- 85.Contini C, Cultrera R, Seraceni S, Castellazzi M, Granieri E, Fainardi E (2004) Cerebrospinal fluid molecular demonstration of Chlamydia pneumonia DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing/remitting multiple sclerosis. Mult Scler 10(4):360–369CrossRefPubMedGoogle Scholar
- 89.Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E et al (2004) Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated with a subset of multiple sclerosis patients with progressive forms. J Neurol Sci 217(2):181–188CrossRefPubMedGoogle Scholar
- 90.Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW, Singer EJ, Komoly S et al (2000) Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. J Neurovirol 6(2):101–108Google Scholar